AzTrials
AzTrials

Sedentary LifestyleNCT02342301

Cardiometabolic Response to Sit-stand Workstations.

A study testing Standing Desk and Traditional Desk in people with Sedentary Lifestyle, run by University of Prince Edward Island at 1 site in Canada.

Completed

Finished. The study has ended and is not enrolling. Results may be posted on the official record.

Official record
Search all trials

Trial summary

We aim to determine if changing a person's workstation from a traditional seated desk to a height adjustable "standing desk" for a period of approximately 3 months is associated with alterations in traditional measures of cardiometabolic risk. Read more about this study

Who is it for?
Ages 18 years and olderHealthy volunteers can take part
Conditions the study is for
Sedentary Lifestyle
What is being tested?
Standing Desk and Traditional Desk
Could I receive a placebo?
No, everyone receives an active treatment
How many people
25 participants
Where
1 siteCanada
Study dates
Sep 2014to Sep 2015
Phase
Interventional
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 18 years and older
  • All sexes
  • Healthy volunteers accepted
  • Adult, Older adult

Who may be able to join

  • male and female participants
  • 18 years of age and older
  • work in an office-based setting.
  • abdominally obese, defined as a waist circumference ≥ 88 cm for women, and 102 cm for men.

Who cannot join

  • glucose lowering medication
  • inability to stand or walk

Trial locations and contacts

1 site in 1 country.

Canada1 site
  • Human Performance and Health Research Lab, University of Prince Edward Island

    Charlottetown, Prince Edward Island, C1A4P3

Other trials in Canada

About this study

We aim to determine if changing a person's workstation from a traditional seated desk to a height adjustable "standing desk" for a period of approximately 3 months is associated with alterations in traditional measures of cardiometabolic risk.

Read the detailed description

The present study will include 24 male and female participants 18 years of age and older who work in an office-based setting. To be included participants must be abdominally obese, defined as a waist circumference ≥ 88 cm for women, and 102 cm for men. All potential participants will be asked to come to the Human Performance Laboratory at University of Prince Edward Island and will be given an opportunity to ask questions about the study, and to read and sign the informed consent form. Once this has taken place, participants will have their waist circumference measured in order to determine whether they meet the above criteria. If not, the individual will be thanked for their time and told that they are not eligible to participate in the current study.

Lab Day 1 (baseline)

Once screening is complete, participants will have glycosylated hemoglobin checked via a simple finger prick and point-of-care analysis of a single drop of blood. (Funding dependent, a second drop of blood may be used to analyze the participant's blood lipid profile- as would be done at a typical doctor's office visit). Next we will measure the participants' resting metabolic rate, by having them lay on a hospital bed while we analyze the oxygen and carbon dioxide concentrations of the air they exhale. This will inform us as to the participant's baseline caloric needs. Blood pressure, height, weight, waist circumference and body composition will be determined following resting metabolic rate, prior to the determination of aerobic fitness using a sub-maximal exercise protocol (see below).

Augmentation Index:

Arterial stiffness will be determined using a Sphygmocor pulse wave applanation tonomoter (Atcor Medical). This device measures arterial pulse waves non-invasively through the skin at the wrist. We will use this same device to analyze the shape of the pulse wave, which will give us information about reflected pulse waves (and thus the stiffness of the arterial tree). The measure of arterial stiffness is non-invasive and pain-free and is taken using a pen-like tool pressed against the participant's skin to detect his or her pulse.

Prior to departing the lab, participants will be instructed on the use of an accelerometer-based activity monitor (20 min), which they will wear for 1 week prior to the desk intervention. During the activity monitor collection week, participants will also be instructed to wear a heart rate belt (non-invasive chest strap) for one day during working hours only (at least 4 hours of data collection) which will be analyzed after the strap is returned to the lab. Participants will then answer an online questionnaire about his/her current physical activity and sedentary behaviors. https://docs.google.com/forms/d/1fjz5ua47KzcdnhCAN7wCDGNbvy-tKSGgZKGGhIKSqQg/viewform?usp=mail_form_link . A similar questionnaire will be used for post- intervention follow-up with the tenses changed and questions about "anticipated" desk use altered to report on "actual" use (participants in the control group will be asked to answer "not applicable" for any questions related to standing desk use on the follow-up questionnaire).

Total participation Time (1.5 hr)

Once the baseline testing session is complete, participants will be randomly allocated to intervention or control groups (12 participants per group). Participants in the intervention group will be asked to complete the below intervention, while those in the control group will be asked to maintain their current lifestyle and office workstation throughout the study.

Intervention- the participant will be given a stand-up desk and asked to use it in place of their normal desk at work. Participants will again be given the activity and HR monitors to wear during the first and last 2 weeks of desk use.

Lab day 2 (post) - all measures from lab day 1 will be repeated as described above.

Aerobic Fitness- Aerobic fitness will be determined using a treadmill-based graded exercise test with analysis of expired gases. The test will consist of 2-3 increasingly more challenging stages of walking/running (through the addition of speed or incline) at a submaximal intensity. The heart rate and oxygen consumption data collected will be used to extrapolate the data to estimate maximal values. All aerobic fitness tests will be administered under the supervision of a Canadian Society for Exercise Physiology Certified Exercise Physiologist. Prior to any exercise all participants will be required to complete a Physical Activity Readiness Questionnaire (PAR-Q+) safe exercise participation screening form for known or suspected chronic disease risk factors (this tool is used for screening purposes only).

Resting metabolic rate will be determined using the same electrochemical analyzers (on the same metabolic cart) as the exercise measures, except a different flowmeter and gas collection system will be used (namely, we will use a canopy rather than a face mask). This will allow the participant to relax and rest normally without the need of having their nose and mouth covered by a rubber mask, as their entire head and shoulders will be contained within a canopy to collect gases. This system is identical to those used in-hospital.

Being tested
Standing Desk, Traditional Desk
Medical subject headings
Sedentary Behavior

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • Standing DeskBehavioural

    Participants will be provided with a standing desk for 3 months

  • Traditional DeskBehavioural

    Participants will use a traditional seated desk for 3 months

Study groups in NCT02342301
Study groupRoleWhat they receive
Standing DeskExperimentalWill use standing desk for 3 months
Receives: Behavioral: Standing Desk
Traditional DeskActive comparatorWill use traditional desk for 3 months
Receives: Behavioral: Traditional Desk

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Glycoslyated Hemoglobin (HbA1C)

    HbA1c will be measured at baseline and 3 months in both conditions in all participants using a bench-top analyzer.

    Measured: 3 months

Secondary outcomes (9)
  1. Sedentary Time

    Sedentary time will be measured at baseline and 3 months using an activPAL inclinometer.

    Measured: 3 months

  2. Aerobic Fitness (VO2max)

    Aerobic Fitness will be measured at baseline and 3 months using a sub-maximal fitness test.

    Measured: 3 months

  3. Augmentation Index

    Augmentation Index will be measured at baseline and 3 months using a Sphygmocor pulse wave applanation tonomoter.

    Measured: 3 months

  4. Waist Circumference

    Waist circumference will be measured at baseline and 3 months at the level of the iliac crest.

    Measured: 3 months

  5. Physical Activity

    Physical activity will be measured at baseline and 3 months using an activPAL inclinometer.

    Measured: 3 months

  6. Triglycerides

    Plasma triglycerides will be measured at baseline and at 3 months using a bench top analyzer.

    Measured: 3 months

  7. Fasting Glucose

    Fasting glucose will be measured at baseline and at 3 months using a bench top analyzer.

    Measured: 3 months

  8. LDL Cholesterol

    LDL Cholesterol will be measured at baseline and at 3 months using a bench top analyzer.

    Measured: 3 months

  9. HDL Cholesterol

    HDL Cholesterol will be measured at baseline and at 3 months using a bench top analyzer.

    Measured: 3 months

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted19 Jan 2015 (estimated)
  2. Study startSep 2014
  3. Primary completionSep 2015
  4. Study completionSep 2015

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Primary purpose
Prevention
Allocation
Randomised
Intervention model
Parallel groups
Masking
None (open label)
Enrolment
25 participants (actual)
IDs, dates and publications
ClinicalTrials.gov ID
NCT02342301
Sponsor's protocol ID
6005871
Status last verified
May 2016
First submitted
14 Jan 2015
Last updated
11 May 2016
Results posted
No
Data monitoring committee
No
Individual data sharing
No

Questions about this trial

What is this clinical trial studying?

A study testing Standing Desk and Traditional Desk in people with Sedentary Lifestyle, run by University of Prince Edward Island at 1 site in Canada.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 4 inclusion and 2 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: finished, as of the sponsor's last update on 11 May 2016. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in Canada. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.

How can a doctor refer a patient or contact the research team?

The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Glycoslyated Hemoglobin (HbA1C) (time frame: 3 months). It is what the study was designed to measure, not a finding.

Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 11 May 2016.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in